• Medical
  • Finance
  • Legal
  • Hemp
  • Marketing
  • Global
  • Podcast
  • Awards
  • Join
  • Sign in
Skip to content
Cannabiz

Cannabiz

The Business of Cannabis

  • Medical
  • Finance
  • Legal
  • Hemp
  • Marketing
  • Global
  • Podcast
  • Awards
  • Join
  • Sign in
Home ยป Andrew Chapman

Tag: Andrew Chapman

Australian firm ECC Pharm expands footprint in Germany with double acquisition

by Steve Jones August 29, 2024August 29, 2024

WA-based ECC Pharm has continued to expand its footprint in Germany with the acquisition of medical […]

ECC Pharm to save ‘a fortune’ after offloading HAPA distribution division

by Steve Jones June 20, 2024June 20, 2024

ECCPharm confirms plan to list on ASX in merger with AusCann

by Steve Jones May 20, 2024May 20, 2024

Company news: AusCann; Avecho; Melodiol Global Health

by Steve Jones April 30, 2024July 16, 2024

Clarity over German legal scheme paves way for AusCann-Eurocann deal

by Steve Jones February 7, 2024February 7, 2024

Quarterly results: Avecho; Melodiol; Bioxyne/BLS; Emyria; Ecofibre; Zelira; Elixinol; AusCann; Botanix

by Steve Jones and Martin Lane January 31, 2024July 11, 2024

Company news: Cann Global; Cann Group; InhaleRx; AusCann; Wellnex Life; Neurotech; MGC Pharma; Stenocare

by Martin Lane December 4, 2023April 30, 2024

AusCann set to import product from Germany under Eurocann tie-up

by Steve Jones July 26, 2023April 30, 2024

AusCann remains in holding pattern as proposed acquisition is delayed

by Steve Jones May 1, 2023April 30, 2024

The curious tale of Eurocann’s journey to ASX listing

by Steve Jones November 10, 2022April 29, 2024

My Account

Sign in

Category

  • Medical
  • Finance
  • Legal
  • Hemp
  • Marketing
  • Global
  • Podcast
  • Awards

About

  • About/contact us
  • Join
  • Sign in
  • Privacy Policy
  • Website Terms & Conditions
  • Membership Terms & Conditions
  • Submit a Guest Post
  • About cannabis
  • Editorial policy
Cannabiz
  • Linkedin
  • Instagram
© 2025 Cannabiz.